The liposarcoma market is expanding due to progress in targeted therapies, immuno-oncology agents, and precision diagnostics for managing soft tissue sarcoma subtypes, particularly in advanced and recurrent disease cases. https://www.datamintelligence.com/research-report/liposarcoma-market